| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 0% stake in AXSOME THERAPEUTICS, INC. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Trevi Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Cogent Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 9.3% stake in Inozyme Pharma, Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 1.3% stake in Provention Bio, Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Annexon, Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 6.8% stake in GH Research PLC |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 4% stake in aTyr Pharma, Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 5.6% stake in Savara Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Celcuity Inc. |
| 11/14/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/28/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.|
Txns:
| Bought 4,674 shares
@ $11.98, valued at
$56k
Bought 170,292 shares
@ $11.67, valued at
$2M
|
|
| 10/11/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.|
Txns:
| Bought 28,900 shares
@ $12, valued at
$346.8k
Bought 80,314 shares
@ $11.89, valued at
$954.9k
Bought 25,000 shares
@ $11.85, valued at
$296.3k
|
|
| 10/06/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.|
Txns:
| Bought 223,100 shares
@ $11.81, valued at
$2.6M
|
|
| 10/03/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.|
Txns:
| Bought 168,187 shares
@ $9.92, valued at
$1.7M
Bought 268,736 shares
@ $11.27, valued at
$3M
|
|
| 09/28/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 16% stake in Tricida, Inc. |
| 09/28/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.|
Txns:
| Bought 395,614 shares
@ $8.56, valued at
$3.4M
Bought 115,000 shares
@ $9.38, valued at
$1.1M
Bought 76,600 shares
@ $9.92, valued at
$759.9k
|
|
| 09/07/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.|
Txns:
| Bought 63,030 shares
@ $12.76, valued at
$804.3k
Bought 150,223 shares
@ $11.43, valued at
$1.7M
Bought 473,459 shares
@ $11.4, valued at
$5.4M
|
|
| 09/01/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.|
Txns:
| Bought 50,000 shares
@ $12.2, valued at
$610k
|
|
| 08/02/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.|
Txns:
| Bought 18,900 shares
@ $9.21, valued at
$174.1k
|
|
| 07/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/08/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 5% stake in Annexon, Inc. |
| 06/23/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|